Evidence map›Paper›PMID 39601043›Full record

Trial reportDiabetes technology & therapeutics2025

Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers with Varying Levels of Baseline Glycemic Control.

Sue A Brown, Lori M Laffel, Halis K Akturk, Gregory P Forlenza, Viral N Shah, R Paul Wadwa, Erin C Cobry, Elvira Isganaitis, Melissa Schoelwer, Virginia S Lu and 5 more

Registry-linked trialAbstract readRandomized Controlled TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Diabetes technology & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05683392 (Control-IQ 2.0 Feasibility Study #2), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05683392 nacompletednot on this map

Control-IQ 2.0 Feasibility Study #2: Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

TypeinterventionalSponsorTandem Diabetes Care, Inc.Ran2023 to 2023Enrolled72ConditionsType 1 DiabetesArmst:slim X2 insulin pump with Control-IQ technology 2.0
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sue A BrownDivision of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Lori M LaffelResearch Division, Joslin Diabetes Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-9675-3001
Halis K AkturkBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0003-4518-5179
Gregory P ForlenzaBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0003-3607-9788
Viral N ShahBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0002-3827-7107
R Paul WadwaBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0002-4139-2122
Erin C CobryBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0002-8494-1814
Elvira IsganaitisResearch Division, Joslin Diabetes Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Melissa SchoelwerDivision of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Virginia S LuTandem Diabetes Care, San Diego, California, USA.
Ricardo RuedaTandem Diabetes Care, San Diego, California, USA.
Nicholas ShererTandem Diabetes Care, San Diego, California, USA.
John P CorbettTandem Diabetes Care, San Diego, California, USA.
Ravid Sasson-KatchalskiTandem Diabetes Care, San Diego, California, USA.
Jordan E PinskerTandem Diabetes Care, San Diego, California, USA.ORCID 0009-0004-7621-5267

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1Glycemic ControlHypoglycemic AgentsInsulinInsulin Infusion SystemsAdolescentAdultBlood GlucoseChildChild, PreschoolCross-Over StudiesFemaleGlycated HemoglobinHumansMaleMealsBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulinControl-IQDKAhypoglycemiat:slim X2type 1 diabetes

Identifiers

PMID39601043
PMCPMC12614758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.